| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Plasmodium falciparum (isolate 3D7) Transmission-blocking |
| | target antigen (a.a.61-460) |
| | Swiss-Prot #: | O96175 |
| | Entry name: | O96175_PLAF7 |
| | Protein | Transmission-blocking target antigen s230 paralog |
| | Gene names: | s230p (PFB0400w) |
| | Organism: | Plasmodium falciparum (isolate 3D7) |
| | Codon-optimized cDNA Clone |
| | Cat#: | RPL-0438 |
| | Description: | Applications:1. Codon-optimized cDNA sequence designed for recombinant |
| | protein production in both E.coli and Mammalian cell. The cDNA has been |
| | cloned into E.coli expression vector with 6x Histidine tag. 2. May be used as |
| | RNAi assistance to restore the loss-of-function. |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Recombinant Protein |
| | Cat#: | PL-0438 |
| | Source: | Recombinant protein derived from E.coli. Or Yeast |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Purity: | > 90%, as determined by SDS-PAGE under reducing conditions |
| | Activity: | N/A |
| | Applications: | Western Blot, may be used for other applications determined by |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Sequence: | | MFIYLFIYLF FKMDKKRTFY YLFFFFTFLV YVLYFDNIKS VLRSSTKKKK KKKICKSTFY VHEESEEIKS WLRNSNERDK |
| | GKKFFIFERL IKERKYICVN KYKRNNKLKW IYKNTYEKTK NICDDYNILF KCIKGIIYDK NKETFFETFF ENFWDNIFYM |
| | NKYIFNIYYY MFDYTKKVKK KIEGIKENMN IRHNNNYNNI FYVHKFFLFN DDEEKKKRND DIKINIKLHN NTRKLSVSEE |
| | NVELKPYIKQ GERNETVVNL YEYFTGGVKR SNNNNEIVVT STEQFHRIVI ICFKPTVKHS HIITSPHDAL NHIVEENDKI |
| | KLSEEIYSIP FYPIYGNLGL KNVITTGIVE FMIPYFSRTQ MNFTVTCANG EMNDLYKFED LIKIRIRIPR NTKKILGLST |
| | NEKDKTVFER IVDNTSNEYR FKSYNNKIVG IKLENSILDP PGCFKTVYED DKILQLEVFL QYVKCINLDR DNYKIRFFFL |
| | PEDFGDEEIE FSCKFTYKKK TSKIIFGLGE TSVDKDIFYL EDEHVKLNIN QDISGDEPYY SHLNYNGIPY NICNFQYKSE |
| | YDSQVCERTI HEFSLFIYNC DTLVGTQIQT TEPITSVKYL NSTYPINKFS DITLLSKDID IEGLEEAFRN SKFFLTSYIN |
| | HGPFPLIIEC VISNSNKDYQ NVYILLHLRT SIKNRSVSFC DFEKVQGYNY LNNYIDGKIC NINITSNSVF GFRCPSNSIK |
| | EPKDCFSQVY IDKKVYKLND KLSNKLILYS MKQENLAIAG FNNYISNSFS FECYCIDKNQ TYSSYERTSG EDIFNHIVKR |
| | IHVHYKNYDE LYDYNIHDKI TYEPIMKNPP ITYLCDFLNK KQILQPLNNK TKNYICTIWY PKPLNYIALN CPTNRRDEQN |
| | DQTISEVYNS LQKDLLKPTG IEQQIDQKKK ELNLLFNKRN IYSNLYHLPK NAPKRTINKN GLNIVNIDEI IPGILIKDVI |
| | NMKLEDVIKP DLLTPTSFLH KTYNTNKSYL FSTRNKSTSV FNTPSIYTPL THTSFSISPK SVPLTKSRIE ETHSSSNTYE |
| | QYIGKRNSIE NGFFIFQLPP YLKKNQTIEF ACINDSTIKN KNVGNNGIMT IHLKSFGNPI EGCYFYKNSA KYNYLKKSIK |
| | IDDLKKEECT IRSDGEIEFV GIMCPYENNL YLTPSSCFLK TYDNTDNLVE LLDINENFEY YSNDKGISYL KIPQEFLNHV |
| | HLFCYCNVDK DSVSDTNVLV KKENKISLEL NYSNKGFNII KTIDYQYEAD ILIGYSYYFK RVTPIYRKKH ICDFTTEDNS |
| | LEPESEDKMI YSCYLSLENN LNFIEVKCPK NKKSSNSEWL FKYGTFDKSS EIMEDDENIK KYEHMKYMPE DKDEIIYLFK |
| | KQKLEDILPG VIIFDKNRYF FEKGNFSFVT PLIVKEDVTI KLLCDNSETK IDDKIGKKGI ILIKIPQHIT DKKFYGCDFS |
| | GDSNKKSSFY YTSVYDLKTQ NQYCEVKLKE NIIISLNCPN GNINPNNCFN NVFLKTNMNE QIHEKIQNIF DQVKVINTKS |
| | HVLLNSSSTF LIISKITKKE LNFFCTCHHN ETKNVGTIYI KNEDIINFSK AYNKESSILQ YIDVTPYYLK DTYICDFTQN |
| | HYSISFDTSV NVQNVLERYL KILSDLYNTH EEFTYFSIHL KLKKEIMKKK YIDYLKKKIN EYKEKETSDK IKRVTLSTND |
| | NINTILVYRC NIDLGSFDKF KIKCPSKLNE EEVENNKLYP NLIYSSNLGL DETDMLNGLT KLLYGSVLIN KTEKNVSFFE |
| | KGELELIISP YTDSSKNIIF SCENVPRNLS KGIIGSASIF IKKNDNKILG CDFIDTPSTL SSASTLESSY GSHASSPLSS |
| | SHHVLHNDNQ GHDVHMINHI DISNKKNSFE FEIELIEGKN TYCNIEAIEN DIVGFSCPYN FLTTPSDCFE SIQIEGVDKE |
| | LETHKLEKLL KGVKILNNDI YKYNFTPSYI ILPKKIKKSL KIFCRCNSVK LIKTGIIQIN IVGDDLNNWF KKEITHNIFA |
| | YQKMDYFYDF SKGPTNISSE NVLGISTMSL MSSNKKVSRK KNHKEENRTQ QNVYKEIEND HKNINENVNK YDNLPVTLLS |
| | SDEGDGYQAD EDIGGEDDAE DVDGEGDDED DNILNPLRTK QVYDIIVAAS EFSKIEVVCP LRNSSQFRQS KISPENFFEY |
| | VYVLEDKNDD KRKRSIEENE KLVKAILEGK KNIDGHIINI EDINNKKSSK NASVEYDDMG NKIFISIISE KPKAVIGDNI |
| | For pricing and availability Click Here >>> |
| | Protein-cDNA-Transmission-blocking-target-antigen-s230-Plasmodium |
| | FOR in vitro RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
|
| ||||||||||||||||||||||||||||||||||
| |||||
| For cDNA or Recombinant Protein Search (Input Cat#, Gene name, Protein Name, Accession Number |
|
Copyright Bioclone Inc All rights Reserved